跳至主要内容
临床试验/NCT01641770
NCT01641770已完成3 期

Oral Nutritional Supplementation in Hospital Patients

Abbott Nutrition13 个研究点 分布在 1 个国家目标入组 212 人开始时间: 2010年10月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
212
试验地点
13
主要终点
Changes from baseline in Body weight

研究概览

简要总结

The study objective is to evaluate the benefits of Oral Nutritional Supplementation (ONS) plus Dietary Counseling (DC) in newly admitted hospital subjects with moderate or severe malnutrition.

详细描述

Approximately 212 subjects (men and women) from multiple Institutions in India will participate in this study. Eligible subjects will be randomized into 2 treatment groups.

  • Dietary Counseling only (n=106)
  • Dietary Counseling + ONS (n=106)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥ 18 years of age
  • Recently admitted into hospital ≤36 hrs.
  • Identified as having "moderate malnutrition" or "severe malnutrition".
  • Anticipated length of hospital stay of at least 3 days.
  • Life expectancy of ≥ 12 weeks
  • Able to consume foods and beverages orally.
  • Willing to abstain from nutritional supplements throughout the study period unless provided be study.

排除标准

  • Alcohol or substance abuse, severe dementia, brain metastases, eating disorders or any psychological condition that may interfere with dietary intake, severe nausea, dysphagia, vomiting, diarrhea, active gastritis, gastrointestinal bleeding or other gastrointestinal disturbances.
  • Diabetes, burn injury covering greater than or equal to 15% of the body, advanced renal or hepatic disease, active malignancy.
  • Ascites, pleural effusion, severe edema or dehydration.
  • Severe edema.
  • Medications/ supplements/substances that could profoundly modulate metabolism or weight
  • Active tuberculosis, acute Hepatitis B or C, or HIV.

结局指标

主要结局

Changes from baseline in Body weight

时间窗: baseline and weeks 4, 8, 12

次要结局

  • Nutrition Assessment(baseline and week 12)
  • BMI(baseline and week 12)
  • Blood Chemistries (pre-albumin g/L, alpha-1 acid glycoprotein g/L)(baseline and weeks 4,8,12)
  • Blood Chemistries (albumin gm/dL, hemoglobin gm/dL, total protein gm/dL)(baseline and weeks 4, 8, 12)
  • Blood Chemistries (glucose mg/dL, creatinine mg/dL)(Baseline and weeks 4,8,12)
  • Blood Chemistries (c-reactive protein mg/L)(Baseline and weeks 4,8,12)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验